Finding equitable health regulations. Uncured illnesses and increasing last - line
resistance call for both fuelling pharmaceutical R&D and the promotion of fair
access to medicine worldwide. How should the EU promote innovation in the
pharmaceutical sector while making existing cures available to those who need
them most?